ZYME SOLUTIONS

zyme-solutions-logo

Zyme Solutions is the leading provider of channel data integrity and channel intelligence solutions to the high-tech and consumer electronics industry. Zyme was founded in 2004 to address the need for technology companies to intelligently manage global indirect channel sales and inventory data and increase channel visibility. Today, industry leaders like Symantec, Xerox, Linksys and Sandisk use Zyme's proven services to manage their sales channels

#People #Financial #Event #Website #More

ZYME SOLUTIONS

Social Links:

Industry:
Hardware Management Information Systems Software

Founded:
2004-01-01

Address:
Redwood Shores, California, United States

Country:
United States

Website Url:
http://www.zyme.com

Total Employee:
251+

Status:
Closed

Contact:
650-551-9900

Email Addresses:
[email protected]

Total Funding:
12.04 M USD

Technology used in webpage:
Domain Not Resolving U.S. Server Location ATT



Current Advisors List

josh-elser_image

Josh Elser Board Observer @ Zyme Solutions
Board_observer
2013-03-01

amir-goldman_image

Amir Goldman Board Member @ Zyme Solutions
Board_member
2013-01-01

amit-shah_image

Amit Shah Board of Directors @ Zyme Solutions
Board_member

bruce-hansen_image

Bruce Hansen Member of the Board of Directors @ Zyme Solutions
Board_member

Current Employees Featured

mukund-ramaratnam_image

Mukund Ramaratnam
Mukund Ramaratnam Vice President of Marketing @ Zyme Solutions
Vice President of Marketing
2010-01-01

daya-kori_image

Daya Kori
Daya Kori Vice President and General Manager @ Zyme Solutions
Vice President and General Manager

Founder


chandran-sankaran_image

Chandran Sankaran

ted-dimbero_image

Ted Dimbero

Acquisitions List

Date Company Article Price
2017-08-03 CCI Nouvelle-Calédonie CCI Nouvelle-Calédonie acquired by Zyme Solutions N/A

Investors List

susquehanna-growth-equity_image

Susquehanna Growth Equity

Susquehanna Growth Equity investment in Venture Round - Zyme Solutions

artiman-ventures_image

Artiman Ventures

Artiman Ventures investment in Series A - Zyme Solutions

Newest Events participated

dreamforce-2017_event_image Participated in Dreamforce 2017 on 2017-11-06 as sponsor

dreamforce-2016_event_image Participated in Dreamforce 2016 on 2016-10-04 as sponsor

Official Site Inspections

http://www.zyme.com

  • Host name: 23.185.0.3
  • IP address: 23.185.0.3
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Zyme Solutions"

Zymeworks - Wikipedia

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds accordi…See details»

Zyem by Mo Glover | Style Uniting The Generations

Color Of Change is the nation’s largest online racial justice organization. We help people respond effectively to injustice in the world around us. As a national online force driven by 7 million members, we move decision-makers in corporations and government to create a more human and less hostile world for Black people in America.See details»

Investor Relations | Zymeworks Inc.

Oct 31, 2024 Who We Are Making a Meaningful Difference. Zymeworks is a publicly listed (NASDAQ: ZYME) Zymeworks is a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the …See details»

Who We Are - Zymeworks

Who We Are Zymeworks is a global biotechnology company developing novel, multifunctional therapeutics to address difficult-to-treat cancers and other serious diseases. We are driven by our mission to make a meaningful difference for people around the world who are impacted by difficult-to-treat cancers and other serious diseases. Our complementary therapeutic platforms …See details»

Zymeworks Company Profile | Management and Employees List

Zymeworks Profile and History. Zymeworks, founded in 2003 and based in Vancouver, BC, is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.See details»

Zymeworks - The Org

Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.See details»

Zymeworks Inc. - LinkedIn

Zymeworks Inc. | 28,117 followers on LinkedIn. Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases. | Zymeworks is a global clinical-stage ...See details»

Zymeworks - Crunchbase Company Profile & Funding

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. The company is committed to developing best-in-class protein therapeutics for the treatment of cancer, autoimmune, and inflammatory diseases.See details»

Zymeworks Inc. (ZYME) Company Profile & Facts - Yahoo Finance

See the company profile for Zymeworks Inc. (ZYME) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their compensation.See details»

ZYME | Zymeworks Inc. Profile - MarketWatch

Zymeworks Inc. Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics.See details»

Zymeworks Announces Additional Leadership Appointments

Jan 4, 2024 These additions to the leadership team highlight Zymeworks' commitment to nurturing and advancing internal talent to key leadership roles while strengthening the capabilities and experience of the organization. "At Zymeworks, we recognize that our greatest asset is our people. Elevating talented individuals is a reflection of their strong ...See details»

Zymeworks Inc. (ZYME) Company Profile & Overview - Stock Analysis

Apr 28, 2017 Company profile for Zymeworks Inc. (ZYME) with a description, list of executives, contact details and other key facts.See details»

Technology — Zymeworks

Our Technology Engineering Fit-for-Purpose Biotherapeutics Our technology leverages Zymeworks’ industry leading expertise in the fields of protein engineering and drug chemistry to discover and develop the next generation of antibody-based therapeutics to combat unmet medical need in hard-to-treat cancers and other serious diseases. The integration of …See details»

Zymeworks Provides Corporate Update on Key Strategic Priorities …

Jan 4, 2023 Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced updated key sSee details»

Zymeworks: A Somewhat Complicated Story - Seeking Alpha

Zymeworks Inc. is a Vancouver-based oncology focused clinical stage biopharma firm whose lead candidate is advancing on numerous fronts. Read more on ZYME stock update.See details»

Zyme Company Profile - - Supply Chain 24/7

ƒf äRÕþk³©Öx â "•‚qIŽé¢Fã ˆ% x$™gkæ5íïÛ ´ÖR!„JI3»ÿŽ©ÍÜ.bšÜâ[B´AÊâ H¦ B" Zâ1\]~¥ ,DÆ̳ /Ff ƒÃ— ¢Ö4 Õ™Œ nñÀGi--¸uè Yû¬9"¡HÿU—H _ wÖdR!4 šð¸®*UìàRC§— G" XËi^"#$ׂ Št Ÿ¦K¹BÖ& ‚ ¢ d àžÃ …™2kAA¥N çyîÂIø«.1¤A(¯SÓתâ9Þq_„“PÖ—ÐyOÒ+tC±; 6ï·^*éŠ#î1œ„ª ”V{ Æa -Àd Ã-@ ÓF ...See details»

Zyme - Biotech Consultancy

Welcome to Zyme Biotech, the leading expert in pharmaceutical consulting. Our commitment is to power breakthroughs in the biotech industry by providing strategic insights, robust solutions, and innovative approaches tailored to your unique needs.See details»

Our Science - Zymeworks

Our Science Zymeworks is utilizing our experience and capabilities to generate a product pipeline of novel, multifunctional therapeutics Revolutionary technologies engineering fit-for-purpose biotherapeutics Our fully integrated R&D pipeline from target selection through to pivotal studies is powered by our team of world-class researchers with the experience to discover, develop and ...See details»

Zymeworks Announces Participation in Upcoming Investor

Jul 30, 2024 VANCOUVER, British Columbia, July 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...See details»